- Home
- BACQ vs ORIC Comparison
BACQ vs ORIC Comparison
Compare BACQ & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BACQ
- ORIC
- Stock Information
- Founded
- BACQ 2024
- ORIC 2014
- Country
- BACQ United States
- ORIC United States
- Employees
- BACQ N/A
- ORIC N/A
- Industry
- BACQ
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- BACQ
- ORIC Health Care
- Exchange
- BACQ NYSE
- ORIC Nasdaq
- Market Cap
- BACQ 333.2M
- ORIC 362.9M
- IPO Year
- BACQ 2024
- ORIC 2020
- Fundamental
- Price
- BACQ $10.15
- ORIC $5.08
- Analyst Decision
- BACQ
- ORIC Strong Buy
- Analyst Count
- BACQ 0
- ORIC 8
- Target Price
- BACQ N/A
- ORIC $18.83
- AVG Volume (30 Days)
- BACQ 271.4K
- ORIC 630.2K
- Earning Date
- BACQ 01-01-0001
- ORIC 05-05-2025
- Dividend Yield
- BACQ N/A
- ORIC N/A
- EPS Growth
- BACQ N/A
- ORIC N/A
- EPS
- BACQ N/A
- ORIC N/A
- Revenue
- BACQ N/A
- ORIC N/A
- Revenue This Year
- BACQ N/A
- ORIC N/A
- Revenue Next Year
- BACQ N/A
- ORIC N/A
- P/E Ratio
- BACQ $112.74
- ORIC N/A
- Revenue Growth
- BACQ N/A
- ORIC N/A
- 52 Week Low
- BACQ $9.80
- ORIC $3.90
- 52 Week High
- BACQ $10.14
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- BACQ N/A
- ORIC 44.71
- Support Level
- BACQ N/A
- ORIC $4.52
- Resistance Level
- BACQ N/A
- ORIC $5.83
- Average True Range (ATR)
- BACQ 0.00
- ORIC 0.52
- MACD
- BACQ 0.00
- ORIC 0.07
- Stochastic Oscillator
- BACQ 0.00
- ORIC 40.58
About BACQ BLEICHROEDER ACQUISITION CORP. I
Bleichroeder Acquisition Corp I is a blank check company.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.